Tapewire

Nasdaq · USD

CADL

Candel Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4969
SEC CIK
0001841387
Parsed reports
200

Last 12 months

Inside the activity.

1 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202601
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 20, 2024 Filed Dec 26, 2024 18:59 UTC Disposition to issuerCADL 100,000 $9.00 $900,000.00
Disclosure

SEC source: 0001873919-24-000010 · primary_doc.xml · nonDerivative · entry 2

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 331,443

F1 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

Read SEC document
December 20, 2024 Filed Dec 26, 2024 18:59 UTC Disposition to issuerCADL 100,000 $9.00 $900,000.00
Disclosure

SEC source: 0001873919-24-000010 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 373,512

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:11 UTC PurchaseCommon Stock 750,000 $6.00 $4,500,000.00
Disclosure

SEC source: 0000950170-24-137889 · ownership.xml · nonDerivative · entry 2

Manning Paul B · CIK 0001494695 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By BKB Growth Investments, LLC

Disclosed balance after: 1,303,752

F2 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:11 UTC PurchaseCommon Stock 500,000 $6.00 $3,000,000.00
Disclosure

SEC source: 0000950170-24-137889 · ownership.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Paul B. Manning Revocable Trust

Disclosed balance after: 1,142,406

F1 · ownership.nature: The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 23:12 UTC Disposition to issuerCADL 200,000 $10.04 $2,008,000.00
Disclosure

SEC source: 0001873919-24-000009 · primary_doc.xml · nonDerivative · entry 4

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 431,443

F1 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

Read SEC document
December 12, 2024 Filed Dec 13, 2024 23:12 UTC Disposition to issuerCADL 200,000 $10.04 $2,008,000.00
Disclosure

SEC source: 0001873919-24-000009 · primary_doc.xml · nonDerivative · entry 3

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 473,512

Read SEC document
December 11, 2024 Filed Dec 13, 2024 23:12 UTC Disposition to issuerCADL 200,000 $8.53 $1,706,000.00
Disclosure

SEC source: 0001873919-24-000009 · primary_doc.xml · nonDerivative · entry 2

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 631,443

F1 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

Read SEC document
December 11, 2024 Filed Dec 13, 2024 23:12 UTC Disposition to issuerCADL 200,000 $8.53 $1,706,000.00
Disclosure

SEC source: 0001873919-24-000009 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 673,512

Read SEC document
December 06, 2024 Filed Dec 6, 2024 23:44 UTC Disposition to issuerCADL 20,000 $5.23 $104,600.00
Disclosure

SEC source: 0001873919-24-000008 · primary_doc.xml · nonDerivative · entry 3

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,335

F1 · balance_after: Shares of common stock held jointly with spouse

Read SEC document
December 05, 2024 Filed Dec 6, 2024 23:44 UTC Disposition to issuerCADL 20,000 $4.79 $95,800.00
Disclosure

SEC source: 0001873919-24-000008 · primary_doc.xml · nonDerivative · entry 2

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,335

F1 · balance_after: Shares of common stock held jointly with spouse

Read SEC document
December 04, 2024 Filed Dec 6, 2024 23:44 UTC Disposition to issuerCADL 20,000 $4.46 $89,200.00
Disclosure

SEC source: 0001873919-24-000008 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,335

F1 · balance_after: Shares of common stock held jointly with spouse

Read SEC document
November 29, 2024 Filed Dec 3, 2024 22:46 UTC
Barone FrancescaChief Scientific Officer
SaleCommon Stock 22,081 $4.56 $100,592.20
Disclosure

SEC source: 0000950170-24-132925 · ownership.xml · nonDerivative · entry 1

Barone Francesca · CIK 0001909680 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,880

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
November 29, 2024 Filed Dec 3, 2024 22:48 UTC
Tyagarajan SeshuChief Technology Officer
SaleCommon Stock 20,392 $4.56 $92,897.80
Disclosure

SEC source: 0000950170-24-132932 · ownership.xml · nonDerivative · entry 1

Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,657

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
November 29, 2024 Filed Dec 3, 2024 17:47 UTC
Nichols William GarrettChief Medical Officer
SaleCommon Stock 13,935 $4.56 $63,482.29
Disclosure

SEC source: 0000950170-24-132928 · ownership.xml · nonDerivative · entry 1

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,547

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
November 29, 2024 Filed Dec 3, 2024 22:48 UTC
Tak Paul PeterDirector · Chief Executive Officer
SaleCommon Stock 48,847 $4.56 $222,527.39
Disclosure

SEC source: 0000950170-24-132930 · ownership.xml · nonDerivative · entry 1

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 294,788

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
November 25, 2024 Filed Nov 27, 2024 23:24 UTC Disposition to issuerCADL 20,000 $4.97 $99,400.00
Disclosure

SEC source: 0001873919-24-000006 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,335

F1 · balance_after: Shares of common stock held jointly with spouse

Read SEC document
November 21, 2024 Filed Nov 21, 2024 20:07 UTC
Tak Paul PeterDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 12,900 $0.00 Strike: $1.55 $0.00
Disclosure

SEC source: 0000950170-24-129677 · ownership.xml · derivative · entry 2

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,763,968

Underlying: Common Stock · 12,900 shares

Expires 2030-10-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 25% of this option vested and became exercisable on October 10, 2020, with another 25% vesting on October 10, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Read SEC document
November 21, 2024 Filed Nov 21, 2024 20:07 UTC
Tak Paul PeterDirector · Chief Executive Officer
Exercise / conversionCommon Stock 12,900 $1.55 $19,995.00
Disclosure

SEC source: 0000950170-24-129677 · ownership.xml · nonDerivative · entry 1

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 343,635

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 08, 2024 Filed Nov 9, 2024 01:58 UTC Disposition to issuerCADL 7,500 $4.92 $36,900.00
Disclosure

SEC source: 0001873919-24-000005 · primary_doc.xml · nonDerivative · entry 6

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 831,443

F1 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

Read SEC document
November 08, 2024 Filed Nov 9, 2024 01:58 UTC Disposition to issuerCADL 7,500 $4.92 $36,900.00
Disclosure

SEC source: 0001873919-24-000005 · primary_doc.xml · nonDerivative · entry 5

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 873,512

Read SEC document
November 07, 2024 Filed Nov 9, 2024 01:58 UTC Disposition to issuerCADL 7,500 $5.19 $38,925.00
Disclosure

SEC source: 0001873919-24-000005 · primary_doc.xml · nonDerivative · entry 4

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 838,943

F1 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

Read SEC document
November 07, 2024 Filed Nov 9, 2024 01:58 UTC Disposition to issuerCADL 7,500 $5.19 $38,925.00
Disclosure

SEC source: 0001873919-24-000005 · primary_doc.xml · nonDerivative · entry 3

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 881,012

Read SEC document
November 06, 2024 Filed Nov 9, 2024 01:58 UTC Disposition to issuerCADL 7,500 $5.33 $39,975.00
Disclosure

SEC source: 0001873919-24-000005 · primary_doc.xml · nonDerivative · entry 2

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 846,443

F1 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

Read SEC document
November 06, 2024 Filed Nov 9, 2024 01:58 UTC Disposition to issuerCADL 7,500 $5.33 $39,975.00
Disclosure

SEC source: 0001873919-24-000005 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 888,512

Read SEC document
November 01, 2024 Filed Nov 1, 2024 22:08 UTC Disposition to issuerCADL 7,500 $5.27 $39,525.00
Disclosure

SEC source: 0001873919-24-000004 · primary_doc.xml · nonDerivative · entry 6

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 853,943

F2 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

Read SEC document
November 01, 2024 Filed Nov 1, 2024 22:08 UTC Disposition to issuerCADL 7,500 $5.27 $39,525.00
Disclosure

SEC source: 0001873919-24-000004 · primary_doc.xml · nonDerivative · entry 5

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 896,012

Read SEC document
October 31, 2024 Filed Nov 1, 2024 22:08 UTC Disposition to issuerCADL 7,500 $5.30 $39,750.00
Disclosure

SEC source: 0001873919-24-000004 · primary_doc.xml · nonDerivative · entry 4

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 861,443

F2 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

Read SEC document
October 31, 2024 Filed Nov 1, 2024 22:08 UTC Disposition to issuerCADL 7,500 $5.30 $39,750.00
Disclosure

SEC source: 0001873919-24-000004 · primary_doc.xml · nonDerivative · entry 3

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 903,512

Read SEC document
October 30, 2024 Filed Nov 1, 2024 22:08 UTC Disposition to issuerCADL 6,000 $5.38 $32,280.00
Disclosure

SEC source: 0001873919-24-000004 · primary_doc.xml · nonDerivative · entry 2

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 868,943

F2 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

Read SEC document
October 30, 2024 Filed Nov 1, 2024 22:08 UTC Disposition to issuerCADL 6,000 $5.38 $32,280.00
Disclosure

SEC source: 0001873919-24-000004 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 911,012

F1 · balance_after: Adjusted by 28,480 shares acquired by Dr. Aguilar-Cordova through option exercise as previously filed on 09/23/2024

Read SEC document
October 28, 2024 Filed Oct 28, 2024 22:41 UTC Disposition to issuerCADL 11,711 $5.58 $65,347.38
Disclosure

SEC source: 0001873919-24-000003 · primary_doc.xml · nonDerivative · entry 4

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 888,532

Read SEC document
October 25, 2024 Filed Oct 28, 2024 22:41 UTC Disposition to issuerCADL 1,597 $5.80 $9,262.60
Disclosure

SEC source: 0001873919-24-000003 · primary_doc.xml · nonDerivative · entry 3

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900,243

Read SEC document
October 24, 2024 Filed Oct 28, 2024 22:41 UTC Disposition to issuerCADL 1,194 $5.72 $6,829.68
Disclosure

SEC source: 0001873919-24-000003 · primary_doc.xml · nonDerivative · entry 2

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 901,840

Read SEC document
October 24, 2024 Filed Oct 28, 2024 22:41 UTC Disposition to issuerCADL 16,427 $5.53 $90,841.31
Disclosure

SEC source: 0001873919-24-000003 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 903,034

Read SEC document
October 15, 2024 Filed Oct 15, 2024 21:59 UTC SaleCADL 10,412 $6.03 $62,784.36
Disclosure

SEC source: 0001873919-24-000002 · primary_doc.xml · nonDerivative · entry 3

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 919,461

Read SEC document
October 14, 2024 Filed Oct 15, 2024 21:59 UTC SaleCADL 15,000 $6.02 $90,300.00
Disclosure

SEC source: 0001873919-24-000002 · primary_doc.xml · nonDerivative · entry 2

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 929,873

Read SEC document
October 11, 2024 Filed Oct 15, 2024 21:59 UTC SaleCADL 15,000 $6.05 $90,750.00
Disclosure

SEC source: 0001873919-24-000002 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 944,873

Read SEC document
October 03, 2024 Filed Oct 3, 2024 22:19 UTC SaleCADL 1,800 $6.85 $12,330.00
Disclosure

SEC source: 0001873919-24-000001 · primary_doc.xml · nonDerivative · entry 3

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 959,873

Read SEC document
October 02, 2024 Filed Oct 3, 2024 22:19 UTC SaleCADL 26,988 $6.92 $186,756.96
Disclosure

SEC source: 0001873919-24-000001 · primary_doc.xml · nonDerivative · entry 2

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 961,673

Read SEC document
October 01, 2024 Filed Oct 3, 2024 22:19 UTC SaleCADL 6,214 $7.01 $43,554.55
Disclosure

SEC source: 0001873919-24-000001 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 988,661

Read SEC document
July 17, 2024 Filed Jul 19, 2024 12:24 UTC
Barone FrancescaChief Scientific Officer
SaleCommon Stock 14,051 $6.47 $90,946.50
Disclosure

SEC source: 0000950170-24-084758 · ownership.xml · nonDerivative · entry 1

Barone Francesca · CIK 0001909680 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,961

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
July 17, 2024 Filed Jul 19, 2024 08:28 UTC
Schoch CharlesSee Remarks
SaleCommon Stock 9,884 $6.47 $63,975.18
Disclosure

SEC source: 0000950170-24-084760 · ownership.xml · nonDerivative · entry 1

Schoch Charles · CIK 0002007349 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,520

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
July 17, 2024 Filed Jul 19, 2024 12:31 UTC
Tyagarajan SeshuChief Technology Officer
SaleCommon Stock 14,851 $6.47 $96,124.58
Disclosure

SEC source: 0000950170-24-084762 · ownership.xml · nonDerivative · entry 1

Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,049

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
July 17, 2024 Filed Jul 19, 2024 08:26 UTC
Nichols William GarrettChief Medical Officer
SaleCommon Stock 10,875 $6.47 $70,389.53
Disclosure

SEC source: 0000950170-24-084759 · ownership.xml · nonDerivative · entry 1

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,482

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
July 17, 2024 Filed Jul 19, 2024 12:29 UTC
Tak Paul PeterDirector · Chief Executive Officer
SaleCommon Stock 22,528 $6.47 $145,814.73
Disclosure

SEC source: 0000950170-24-084761 · ownership.xml · nonDerivative · entry 1

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,735

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
July 11, 2024 Filed Jul 15, 2024 12:30 UTC
Barone FrancescaChief Scientific Officer
SaleCommon Stock 12,645 $5.97 $75,533.64
Disclosure

SEC source: 0000950170-24-083396 · ownership.xml · nonDerivative · entry 1

Barone Francesca · CIK 0001909680 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,012

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
July 11, 2024 Filed Jul 15, 2024 08:34 UTC
Schoch CharlesSee Remarks
SaleCommon Stock 8,897 $5.97 $53,145.34
Disclosure

SEC source: 0000950170-24-083399 · ownership.xml · nonDerivative · entry 1

Schoch Charles · CIK 0002007349 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,404

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
July 11, 2024 Filed Jul 15, 2024 12:36 UTC
Tyagarajan SeshuChief Technology Officer
SaleCommon Stock 13,330 $5.97 $79,625.42
Disclosure

SEC source: 0000950170-24-083403 · ownership.xml · nonDerivative · entry 1

Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,900

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
July 11, 2024 Filed Jul 15, 2024 08:32 UTC
Nichols William GarrettChief Medical Officer
SaleCommon Stock 9,769 $5.97 $58,354.14
Disclosure

SEC source: 0000950170-24-083397 · ownership.xml · nonDerivative · entry 1

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,357

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document
July 11, 2024 Filed Jul 15, 2024 12:35 UTC
Tak Paul PeterDirector · Chief Executive Officer
SaleCommon Stock 20,293 $5.97 $121,218.21
Disclosure

SEC source: 0000950170-24-083401 · ownership.xml · nonDerivative · entry 1

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 353,263

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.